Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure

Clinica Chimica Acta

Volumn 411, Issue 13-14, 2010, Pages 936-939

  McGill, Darryl ^a,b   Talaulikar, Girish ^a,b   Potter, Julia M ^a,b   Koerbin, Gus ^a   Hickman, Peter E ^a,b  

^a CANBERRA HOSPITAL   (Australia)

^b The Australian National University   (Australia)

Author keywords

Death; Dialysis; NT proBNP; Troponin T

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; NATRIURETIC FACTOR; NATRIURETIC PROTEIN TYPE B; TRINITROTOLUENE; TROPONIN T; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ADULT; ARTICLE; BLOOD SAMPLING; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MORBIDITY; OUTCOME ASSESSMENT; PATIENT MONITORING; POPULATION RISK; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS; SURVIVAL RATE;

BIOLOGICAL MARKERS; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS; TROPONIN T;

EID: 77952544006     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.03.004     Document Type: Article

References (14)

1. McDonald S, Excell L, Livingston B. Chapter 3 Deaths. The Thirty First Report Australia and New Zealand Dialysis and Transplant Registry. Eds McDonald S, Excell L, Livingston B. , (accessed 24th January 2010). http://www.anzdata.org.au/anzdata/AnzdataReport/31stReport/Ch03Deaths.pdf.
2. Ooi D.S., Veinot J.P., Wells G.A., House A.A. Increased mortality in hemodialyzed patients with elevated serum troponin T: a one-year outcome study. Clin Biochem 1999, 32:647-652.
3. Dierkes J., Domrose U., Westphal S., et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000, 102:1964-1969.
4. Hickman P.E., Koerbin G., Southcott E., et al. Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease. Ann Clin Biochem 2007, 44:285-289.
5. Reichlin T., Hochholzer W., Bassetti S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
6. Hickman P.E., McGill D.A., Talaulikar G., et al. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J 2009, 39:812-818.
7. Jacobs L.H., van de Kerkhof J., Mingels A.M., et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009, 46:283-290.
8. Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., Murray D.C., Barre P.E. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 1996, 7:728-736.
9. Cooper B.A., Penne E.L., Bartlett L.H., Pollock C.A. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 2004, 43:61-66.
10. Apple F.S., Murakami M.M., Pearce L.A., Herzog C.A. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004, 50:2279-2285.
11. London G.M. Cardiovascular disease in chronic renal failure: pathophysiological aspects. Semin Dial 2003, 16:85-94.
12. Mingels A., Jacobs L., Michielsen E., Swaanenberg J., Wodzig W., van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009, 55:101-108.
13. Kavsak P.A., MacRae A.R., Yerna M.-J., Jaffe A.S. Analytical and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009, 55:573-577.
14. Bergmann O., Bhardwaj R.D., Bernard S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.